11 - 17 November 2017
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts
Gilenya effective for children with MS
The first trial of a disease modifying drug in people under the age of 18 found that Gilenya (fingolimod) reduced the relapse rate by 82%. The headline suggests the drug improved vision and bladder symptoms, though this was not part of the trial. The results were presented at ECTRIMS
Source: Daily Mail
MS Trust link: Childhood MS